About LogicBio
LogicBio is a Healthcare company based in Lexington (United States) founded in 2013, and was acquired by Alexion in October 2022. Viral vectors are developed for genetic and infectious disease treatments. LogicBio has raised $49 million across 3 funding rounds from investors including Alexion, Orbimed and Edmond de Rothschild. Its chief executive, as recorded, is Frederic Chereau. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is LOGICBIO THERAPEUTICS, INC. Its competitors include Spark Therapeutics, AskBio and Unity Biotechnology; 3 of its 3 listed competitors have raised funding.
Company details
LogicBio Therapeutics was founded in 2013 and is headquartered in Lexington, United States. Operations focus on the biotechnology sector, where gene therapy platforms based on non-pathogenic Adeno-Associated Viral (AAV) vectors are developed. These vectors target genetic conditions such as hemophilia and methylmalonic acidemia (MMA), along with infectious diseases including HIVAIDS, for use in both pediatric and adult patients.
- Headquarters Lexington, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website logicbio.com
- Social LinkedIn X YouTube
- Acquired by Alexion (Oct 2022)
- Legal Name Logicbio Therapeutics, Inc.
Apps and channels of LogicBio
its YouTube channel Alexion Pharmaceuticals US has 233 subscribers and 30 videos.
Videos from LogicBio
The most watched videos on LogicBio's YouTube channel, Alexion Pharmaceuticals US (233 subscribers). Click a video to play it here.
More on Alexion Pharmaceuticals US.
Funding Insights of LogicBio
LogicBio has successfully raised a total of $49M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49M
- Total Rounds 3
- Last Round Debt – Conventional — $20M
- First Round $4M
(Jan 2016)
- Investors Count 7
All 3 funding rounds of LogicBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2019 | $20M | Debt – Conventional | – | – | |
| Jul 2017 | $45M | Series B | – | Arix Bioscience | |
| Jan 2016 | $4M | Series A | – | – |
8 investors in total: 8 institutional.
Investors in LogicBio
LogicBio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Alexion, Orbimed and Edmond de Rothschild.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
Investments in biotech startups are made by Arix Bioscience. | 2016 | arixbioscience.com | London, United Kingdom | |
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors | 1953 | edmond-de-rothschild.com | Paris, France | |
Pontifax Venture Capital is focused on life sciences investments. | pontifax.com | Herzeliya, Israel | ||
| sbi-ji.co.il | ||||
Therapies for rare and devastating diseases are developed by Alexion. | 1992 | alexion.com | Zurich, Switzerland |
Investor details for LogicBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LogicBio
170 people are tracked at LogicBio (110 in leadership, 7 in board & advisors, 53 in team).
| Name | Role | Group |
|---|---|---|
Frederic Chereau | CEO & President | Leadership |
Brian Gosper | Associate Director, Sales Operations, Pnh, Hematology And Nephrology Business Unit | Leadership |
Cole Allen | Director, US Strategic Account Lead | Leadership |
Mary-Sheila Leese | Vice President, Patient Services & Strategy | Leadership |
Kevin Siska | Sr. Regional Sales Director, Nf1 PN | Leadership |
Lisa Lavorgna | Director, Patient Services Reporting & Analytics | Leadership |
Mark Hill | Director, US Strategic Account Lead | Leadership |
Faraz Lutfi | Head Of Finance - ANZ & China | Leadership |
Adam Pool | IDN Director, Strategic Account Lead | Leadership |
Sean Christie | Chief Financial and Administration Officer | Leadership |
Marc Dunoyer | Chief Executive Officer | Leadership |
Sarah Marshall | VP, Head of Human Resources | Leadership |
Matthew L. Keesecker | Regional Sales Director - Neurology | Leadership |
Wei Shao | Associate Director, Strategy And Business Development | Leadership |
Toby Freyman | Vice President Of Business Development | Leadership |
Suliya Maimaitiming Madani | Executive Director | Leadership |
Cho Yoonjoo | Representative Director, Alexion Pharma Korea Llc. | Leadership |
Michael Gregersen | Finance Business Partner, Hematology & Nephrology | Leadership |
Sofia Pacheco | Associate Director, Strategy & Business Development | Leadership |
Gordon Rust | Executive Director - US Sales, Complement Division | Leadership |
150 more people are available in the full profile.
Complete people profiles for LogicBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LogicBio
5 dated milestones of LogicBio across 9 years, from founding to its latest funding, stage changes and deals.
- Founded LogicBio is founded.
- Funding First funding round of $4.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $20.0M.
- Exit Acquired by Alexion.
Competitors of LogicBio
LogicBio has 3 listed competitors in our database, 3 of them funded. They include Spark Therapeutics, AskBio and Unity Biotechnology.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| askbio.com | 2001 | Durham, United States | $235M | Gene and protein therapies are developed for treating various diseases. | ||
| unitybiotechnology.com | 2016 | San Francisco, United States | $206M | Therapeutics for aging diseases are developed by targeting senescent cells. |
Detailed competitors of LogicBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as LogicBio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Logicbio
Complete news archive for LogicBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LogicBio
LogicBio was founded in 2013 and raised its 1st funding round 3 years after it was founded.
LogicBio is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Frederic Chereau is the CEO of LogicBio, as recorded in our data.
LogicBio is a funded company, having raised a total of $49M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Jan 2016.
LogicBio Therapeutics was founded in 2013 and is headquartered in Lexington, United States. Operations focus on the biotechnology sector, where gene therapy platforms based on non-pathogenic Adeno-Associated Viral (AAV) vectors are developed. These vectors target genetic conditions such as hemophilia and methylmalonic acidemia (MMA), along with infectious diseases including HIVAIDS, for use in both pediatric and adult patients.
LogicBio's top competitors include Spark Therapeutics, AskBio and Unity Biotechnology.
LogicBio has 8 investors. Key investors include Alexion, Orbimed, Edmond de Rothschild, Oxford Finance, and Horizon Tech Finance.
LogicBio operates through Logicbio Therapeutics, Inc..
Yes. LogicBio was acquired by Alexion in October 2022.